At the same time, while the presence of a MYD88 mutation may promote receptor-independent signalling (63), TLR activation also contributes to signal transduction in the context of MYD88-L265P in ABC-DLBCL and in B-cells engineered to express mutant MYD88 (65,66). Here, MYD88 is linked to diffuse large B-cell lymphoma.